AXOL BIOSCIENCE LTD.

In News

Axol Bioscience Raises $2.8M to Advance US Expansion and Product Development - Business Wire

Business Wire - Jan 13, 2026

Axol Bioscience acquires ophthalmology business from Newcells Biotech - the-scientist.com

the-scientist.com - Feb 19, 2026

Advanced Cardiotoxicity Testing Using Multi-Channel iPSC Cardiomyocytes - news-medical.net

news-medical.net - Apr 01, 2026

Jobs saved at Newcastle life sciences firm Newcells Biotech amid partial rescue deal - business-live.co.uk

business-live.co.uk - Feb 19, 2026

Axol Bioscience and StrataStem to Deliver iPSC-Derived ‘Clinical Trial in a Dish’ for Alzheimer’s Disease - BioInformant

BioInformant - Jul 14, 2023

Validation of a cortical tri-culture axoModel™ for in vitro compound screening: A blinded compound study - news-medical.net

news-medical.net - Nov 07, 2024

Venture Capital Funding Flowing into the iPSC Sector by Year - BioInformant

BioInformant - Aug 03, 2025

Axol Bioscience introduces CiPA-validated human stem cell-derived ventricular cardiomyocytes to help improve drug discovery - the-scientist.com

the-scientist.com - Aug 02, 2022

iPSC-Based Neuromuscular and Neuronal Models for ALS and Drug Discovery - news-medical.net

news-medical.net - Sep 16, 2024

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment